- Home
- CRGO vs ARCT Comparison
CRGO vs ARCT Comparison
Compare CRGO & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRGO | ARCT |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 195.4M | 194.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CRGO | ARCT |
|---|---|---|
| Price | $3.12 | $7.21 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $38.67 |
| AVG Volume (30 Days) | 74.6K | ★ 892.4K |
| Earning Date | 11-17-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $28,642,000.00 | ★ $97,601,000.00 |
| Revenue This Year | $26.59 | N/A |
| Revenue Next Year | $23.43 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 27.55 | N/A |
| 52 Week Low | $1.72 | $5.85 |
| 52 Week High | $4.42 | $24.17 |
Technical Indicators
Market Signals| Indicator | CRGO | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 43.82 | 41.39 |
| Support Level | $3.04 | $7.04 |
| Resistance Level | $3.22 | $7.76 |
| Average True Range (ATR) | 0.14 | 0.40 |
| MACD | 0.00 | 0.42 |
| Stochastic Oscillator | 24.14 | 72.25 |
Price Performance
Historical ComparisonAbout CRGO Freightos Limited Ordinary shares
Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.